NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,624,588 | -8.3% | 533,889 | +0.8% | 0.01% | 0.0% |
| Q2 2023 | $25,770,239 | -8.6% | 529,598 | +4.2% | 0.01% | -16.7% |
| Q1 2023 | $28,204,937 | +44.0% | 508,014 | +4.2% | 0.01% | +50.0% |
| Q4 2022 | $19,585,446 | +2.6% | 487,564 | +12.0% | 0.00% | 0.0% |
| Q3 2022 | $19,080,000 | +29.5% | 435,438 | +4.7% | 0.00% | +33.3% |
| Q2 2022 | $14,736,000 | -2.7% | 415,771 | +11.7% | 0.00% | 0.0% |
| Q1 2022 | $15,138,000 | -58.5% | 372,123 | -4.8% | 0.00% | -50.0% |
| Q4 2021 | $36,512,000 | -19.1% | 390,966 | -3.5% | 0.01% | -25.0% |
| Q3 2021 | $45,153,000 | +1.4% | 405,175 | +3.3% | 0.01% | 0.0% |
| Q2 2021 | $44,514,000 | -48.6% | 392,090 | -54.0% | 0.01% | -50.0% |
| Q1 2021 | $86,543,000 | -14.5% | 852,296 | -16.2% | 0.02% | -20.0% |
| Q4 2020 | $101,239,000 | +43.5% | 1,017,266 | +4.1% | 0.02% | +33.3% |
| Q3 2020 | $70,571,000 | +42.5% | 976,899 | -1.6% | 0.02% | +25.0% |
| Q2 2020 | $49,517,000 | +89.3% | 993,115 | +13.4% | 0.01% | +50.0% |
| Q1 2020 | $26,162,000 | -7.1% | 876,140 | +4.8% | 0.01% | +33.3% |
| Q4 2019 | $28,161,000 | +10.2% | 835,836 | +7.3% | 0.01% | 0.0% |
| Q3 2019 | $25,548,000 | +82.9% | 778,894 | +53.8% | 0.01% | +100.0% |
| Q2 2019 | $13,968,000 | +56.0% | 506,488 | +16.6% | 0.00% | +50.0% |
| Q1 2019 | $8,953,000 | +49.0% | 434,209 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $6,009,000 | -41.0% | 430,391 | +1.1% | 0.00% | 0.0% |
| Q3 2018 | $10,190,000 | +47.9% | 425,685 | +16.2% | 0.00% | 0.0% |
| Q2 2018 | $6,891,000 | +97.8% | 366,188 | -2.5% | 0.00% | +100.0% |
| Q1 2018 | $3,483,000 | +4.6% | 375,674 | +1.5% | 0.00% | 0.0% |
| Q4 2017 | $3,329,000 | -28.1% | 370,246 | +3.1% | 0.00% | 0.0% |
| Q3 2017 | $4,631,000 | +20.9% | 359,183 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $3,831,000 | +48.1% | 352,808 | +21.0% | 0.00% | 0.0% |
| Q1 2017 | $2,587,000 | -24.8% | 291,582 | -0.8% | 0.00% | 0.0% |
| Q4 2016 | $3,442,000 | +9.7% | 293,995 | +4.1% | 0.00% | 0.0% |
| Q3 2016 | $3,137,000 | -2.3% | 282,291 | +6.0% | 0.00% | 0.0% |
| Q2 2016 | $3,212,000 | +217.1% | 266,247 | +150.2% | 0.00% | – |
| Q1 2016 | $1,013,000 | -11.5% | 106,397 | +0.4% | 0.00% | – |
| Q4 2015 | $1,145,000 | +310.4% | 105,999 | +313.3% | 0.00% | – |
| Q3 2015 | $279,000 | – | 25,646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |